NCT03969225View on ClinicalTrials.gov

Vascular Access Outcome Measure for Function: a vaLidation Study In haemoDialysis

CompletedOBSERVATIONAL
Enrollment

702

Participants

Timeline

Start Date

December 6, 2019

Primary Completion Date

October 30, 2022

Study Completion Date

February 17, 2023

Conditions
Vascular Access ComplicationHemodialysis Access Failure (Disorder)
Trial Locations (10)

4110

Princess Alexandra Hospital, Brisbane

4740

Mackay Hospital, Mackay

Unknown

Mater Hospital, Brisbane

Hervey Bay Hospital, Hervey Bay

University Health Network, Toronto

Centre Hospitalier Régional Universitaire de Tours, Tours

Hospital Sultanah Aminah Johor Bahru, Johor Bahru

Maastricht University Medical Centre, Maastricht

Ospedale Regionale di Lugano, Lugano

Sheffield Teaching Hospital, Sheffield

All Listed Sponsors
collaborator

Australasian Kidney Trials Network

NETWORK

lead

The University of Queensland

OTHER

NCT03969225 - Vascular Access Outcome Measure for Function: a vaLidation Study In haemoDialysis | Biotech Hunter | Biotech Hunter